Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

Nektar Therapeutics (NKTR)

-NasdaqGS
15.20 Down 0.19(1.23%) Jul 22, 4:00PM EDT
Prev Close:15.39
Open:15.38
Bid:12.04 x 100
Ask:16.14 x 1300
1y Target Est:17.43
Beta:1.24108
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:15.17 - 15.47
52wk Range:9.16 - 17.55
Volume:565,148
Avg Vol (3m):912,917
Market Cap:2.07B
P/E (ttm):N/A
EPS (ttm):-1.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRDown 1.23%2.07B
GSKUp 0.64%106.58B
ENZNUp 0.26%17.38M
BMYUp 0.24%126.33B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.95
Quarterly EPS Est (Jun-16) :-0.30
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):2.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback